Clinical trial · no report yet · Phase 3
ABC-02
Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors
- NCT00262769 ↗
- Completed
- University College, London
- 21 commentary sources found
- Standard
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Commentary we found
Podcasts, YouTube videos and X posts in our index that name this trial. A report screens them, searches for more and cites what clinicians said when it is built.
| Channel | Found | |
|---|---|---|
| YouTube | 8 | |
| Podcasts | 8 | |
| X threads | 5 |
The trial
ClinicalTrials.gov- Official title
- Gemcitabine, Alone or in Combination With Cisplatin, in Patients With Advanced or Metastatic Cholangiocarcinomas and Other Biliary Tract Tumors: A Multicentre, Randomized Phase III Study
- Phase
- Phase 3
- Status
- Completed
- Conditions
- Extrahepatic Bile Duct Cancer; Gallbladder Cancer
- Interventions
- cisplatin; gemcitabine hydrochloride
- Arms
- A - Gemcitabine · Experimental
- B - Gemcitabine and Cisplatin · Experimental
- Enrollment
- 324
- Primary outcomes
- Overall Survival
- Sponsor
- University College, London with Eli Lilly and Company
- Start
- May 2005
- Primary completion
- Aug 2008
- Results posted
- No
- Registry record
- NCT00262769 · updated Jul 17, 2012
Publications
linked from the registry- Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M, Bridgewater J; ABC-02 Trial Investigators. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010 Apr 8;362(14):1273-81. doi: 10.1056/NEJMoa0908721. PubMed 20375404
- Lamarca A, Ross P, Wasan HS, Hubner RA, McNamara MG, Lopes A, Palmer DH, Valle JW, Bridgewater J. Advanced extrahepatic cholangiocarcinoma and gallbladder cancer: Post-hoc analysis of the ABC-01, -02 and -03 clinical trials. JHEP Rep. 2026 Jul;8(7):101833. doi: 10.1016/j.jhepr.2026.101833. Epub 2026 Mar 24. PubMed 41887529